This Article Full Text Full Text (PDF) All Versions of this Article: 94/1/77    most recent 01.RES.0000108262.35847.60v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Platts, S. H. Articles by Duling, B. R. Search for Related Content PubMed PubMed Citation Articles by Platts, S. H. Articles by Duling, B. R. Related Collections Endothelium/vascular type/nitric oxide Other Vascular biology

Adenosine A₃ Receptor Activation Modulates the Capillary Endothelial Glycocalyx

From the Department of Molecular Physiology and Biological Physics and the Cardiovascular Research Center, University of Virginia, Charlottesville, Va.

Correspondence to Brian R. Duling, PhD, Department of Molecular Physiology and Biological Physics, University of Virginia, PO Box 801394, 409 Lane Rd, Room 6051, Charlottesville, VA 22908-1394. E-mail brd{at}virginia.edu

The endothelial glycocalyx is a dynamic extracellular matrix composed of cell surface proteoglycans, glycoproteins, and adsorbed serum proteins that has been implicated in the regulation and modulation of capillary tube hematocrit, permeability, and hemostasis. High tissue adenosine levels have been shown to adversely affect microvascular function and tissue survival after an ischemic episode, and previous work in this laboratory has shown that adenosine causes arteriolar constriction and degranulation of mast cells via the A₃ receptor (A3AR). We hypothesized that adenosine exerts at least part of its effect through modification of the glycocalyx via the A3AR. We used an in vivo cremaster model (hamster and mouse) in which circulating plasma was labeled with a 70-kDa FITC-dextran, and the capillaries were examined before and after superfusion with varying concentrations of adenosine (or other vasoactive molecules). Measurements of the dextran exclusion from an endothelial cell surface layer and red cell separation from the endothelial cell surface were made for up to 30 minutes. Our data indicate that adenosine causes a rapid and profound decrease in the ability of the glycocalyx to exclude dextran but only affects red blood cell exclusion at pharmacological levels. Knockout mice deficient in the A3AR were completely protected from glycocalyx changes attributable to adenosine. These data show a potential link between a known vasoactive tissue metabolite, adenosine, and regulation of the glycocalyx, which may be important during (patho)physiological changes in microvascular function during inflammatory insults.

Key Words: endothelium • inflammation • permeability • mast cells

This article has been cited by other articles:

				D. Chappell, M. Jacob, O. Paul, M. Rehm, U. Welsch, M. Stoeckelhuber, P. Conzen, and B. F. Becker The Glycocalyx of the Human Umbilical Vein Endothelial Cell: An Impressive Structure Ex Vivo but Not in Culture Circ. Res., June 5, 2009; 104(11): 1313 - 1317. [Abstract] [Full Text] [PDF]

				D. R. Potter, J. Jiang, and E. R. Damiano The Recovery Time Course of the Endothelial Cell Glycocalyx In Vivo and Its Implications In Vitro Circ. Res., June 5, 2009; 104(11): 1318 - 1325. [Abstract] [Full Text] [PDF]

				J. W. G. E. VanTeeffelen, A. A. Constantinescu, J. Brands, J. A. E. Spaan, and H. Vink Bradykinin- and sodium nitroprusside-induced increases in capillary tube haematocrit in mouse cremaster muscle are associated with impaired glycocalyx barrier properties J. Physiol., July 1, 2008; 586(13): 3207 - 3218. [Abstract] [Full Text] [PDF]

				D. R. Potter and E. R. Damiano The Hydrodynamically Relevant Endothelial Cell Glycocalyx Observed In Vivo Is Absent In Vitro Circ. Res., April 11, 2008; 102(7): 770 - 776. [Abstract] [Full Text] [PDF]

				P. Cabrales, B. Y. S. Vazquez, A. G. Tsai, and M. Intaglietta Microvascular and capillary perfusion following glycocalyx degradation J Appl Physiol, June 1, 2007; 102(6): 2251 - 2259. [Abstract] [Full Text] [PDF]

				I. Rubio-Gayosso, S. H. Platts, and B. R. Duling Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2247 - H2256. [Abstract] [Full Text] [PDF]

				J. W. G. E. VanTeeffelen, S. Dekker, D. S. Fokkema, M. Siebes, H. Vink, and J. A. E. Spaan Hyaluronidase treatment of coronary glycocalyx increases reactive hyperemia but not adenosine hyperemia in dog hearts Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2508 - H2513. [Abstract] [Full Text] [PDF]

				C. J. Zuurbier, C. Demirci, A. Koeman, H. Vink, and C. Ince Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells J Appl Physiol, October 1, 2005; 99(4): 1471 - 1476. [Abstract] [Full Text] [PDF]

				M. F. Flessner The transport barrier in intraperitoneal therapy Am J Physiol Renal Physiol, March 1, 2005; 288(3): F433 - F442. [Abstract] [Full Text] [PDF]

				T. Kiyooka, O. Hiramatsu, F. Shigeto, H. Nakamoto, H. Tachibana, T. Yada, Y. Ogasawara, M. Kajiya, T. Morimoto, Y. Morizane, et al. Direct observation of epicardial coronary capillary hemodynamics during reactive hyperemia and during adenosine administration by intravital video microscopy Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1437 - H1443. [Abstract] [Full Text] [PDF]